{"data":[{"accessionNo":"0000919574-26-005200","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001370053","issuerName":"ANAPTYSBIO, INC","ticker":"ANAB","cusip":"032724106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Sirenia Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1491959,"percentOfClass":5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000919574-26-005200","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001370053","issuerName":"ANAPTYSBIO, INC","ticker":"ANAB","cusip":"032724106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Alex Silverstein","reportingCik":null,"personType":"HC,IN","sharesOwned":1491959,"percentOfClass":5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000919574-26-003215","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001370053","issuerName":"AnaptysBio, Inc.","ticker":"ANAB","cusip":"032724106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Sirenia Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1920402,"percentOfClass":6.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000919574-26-003215","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001370053","issuerName":"AnaptysBio, Inc.","ticker":"ANAB","cusip":"032724106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Alex Silverstein","reportingCik":null,"personType":"HC,IN","sharesOwned":1920402,"percentOfClass":6.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000919574-26-003483","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001370053","issuerName":"ANAPTYSBIO, INC","ticker":"ANAB","cusip":"032724106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":55303,"percentOfClass":0.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000919574-26-003483","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001370053","issuerName":"ANAPTYSBIO, INC","ticker":"ANAB","cusip":"032724106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":55303,"percentOfClass":0.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000919574-26-003483","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001370053","issuerName":"ANAPTYSBIO, INC","ticker":"ANAB","cusip":"032724106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":55303,"percentOfClass":0.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000102909-26-000635","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001370053","issuerName":"AnaptysBio Inc","ticker":"ANAB","cusip":"032724106","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000895421-26-000034","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001370053","issuerName":"ANAPTYSBIO, INC","ticker":"ANAB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":1006063,"percentOfClass":3.6,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000895421-26-000034","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001370053","issuerName":"ANAPTYSBIO, INC","ticker":"ANAB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Morgan Stanley Capital Services LLC","reportingCik":null,"personType":"BD,CO","sharesOwned":879351,"percentOfClass":3.2,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0001104659-26-004557","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001370053","issuerName":"AnaptysBio, Inc.","ticker":"ANAB","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":813571,"percentOfClass":2.9,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0001104659-26-004557","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001370053","issuerName":"AnaptysBio, Inc.","ticker":"ANAB","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":813571,"percentOfClass":2.9,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0001104659-26-004557","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001370053","issuerName":"AnaptysBio, Inc.","ticker":"ANAB","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":813571,"percentOfClass":2.9,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0001999371-25-017924","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001370053","issuerName":"AnaptysBio Inc.","ticker":"ANAB","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-09-30","reportingPerson":"Mathew P. Arens","reportingCik":null,"personType":"IN","sharesOwned":864618,"percentOfClass":3.12,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0001999371-25-017924","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001370053","issuerName":"AnaptysBio Inc.","ticker":"ANAB","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-09-30","reportingPerson":"First Light Asset Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":770568,"percentOfClass":2.78,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000886982-25-001442","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001370053","issuerName":"ANAPTYSBIO, INC.","ticker":"ANAB","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"GOLDMAN SACHS & CO. LLC","reportingCik":null,"personType":"BD,OO,IA","sharesOwned":1251294.79,"percentOfClass":4.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0000886982-25-001442","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001370053","issuerName":"ANAPTYSBIO, INC.","ticker":"ANAB","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"THE GOLDMAN SACHS GROUP, INC.","reportingCik":null,"personType":"HC,CO","sharesOwned":1251294.79,"percentOfClass":4.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0001104659-25-092506","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001370053","issuerName":"AnaptysBio, Inc.","ticker":"ANAB","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-16","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1426893,"percentOfClass":5.1,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0001104659-25-092506","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001370053","issuerName":"AnaptysBio, Inc.","ticker":"ANAB","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-16","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1426893,"percentOfClass":5.1,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/anab"},{"accessionNo":"0001104659-25-092506","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001370053","issuerName":"AnaptysBio, Inc.","ticker":"ANAB","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-16","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1426893,"percentOfClass":5.1,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/anab"}],"updatedAt":"2026-11-03T23:33:19.460Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/anab","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}